ALAIBAC, MAURO SALVATORE ALESSANDRO
 Distribuzione geografica
Continente #
NA - Nord America 15.259
AS - Asia 2.247
EU - Europa 2.004
SA - Sud America 58
AF - Africa 20
OC - Oceania 17
Continente sconosciuto - Info sul continente non disponibili 6
Totale 19.611
Nazione #
US - Stati Uniti d'America 15.229
SG - Singapore 1.299
CN - Cina 677
IT - Italia 458
DE - Germania 374
FI - Finlandia 304
SE - Svezia 175
GB - Regno Unito 160
HK - Hong Kong 136
FR - Francia 132
RU - Federazione Russa 122
UA - Ucraina 121
VN - Vietnam 83
BR - Brasile 48
NL - Olanda 39
IE - Irlanda 29
AT - Austria 17
ES - Italia 14
CA - Canada 13
IN - India 13
MX - Messico 13
RO - Romania 13
AU - Australia 12
CI - Costa d'Avorio 8
TR - Turchia 8
EG - Egitto 7
BE - Belgio 6
EU - Europa 6
NO - Norvegia 6
HU - Ungheria 5
JP - Giappone 5
NZ - Nuova Zelanda 5
CH - Svizzera 4
IQ - Iraq 4
LT - Lituania 4
PL - Polonia 4
PA - Panama 3
PE - Perù 3
PK - Pakistan 3
PT - Portogallo 3
TW - Taiwan 3
BD - Bangladesh 2
CL - Cile 2
CO - Colombia 2
GR - Grecia 2
HR - Croazia 2
ID - Indonesia 2
KW - Kuwait 2
LA - Repubblica Popolare Democratica del Laos 2
LV - Lettonia 2
PH - Filippine 2
SC - Seychelles 2
SK - Slovacchia (Repubblica Slovacca) 2
ZA - Sudafrica 2
AM - Armenia 1
BG - Bulgaria 1
BO - Bolivia 1
BY - Bielorussia 1
CZ - Repubblica Ceca 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
EC - Ecuador 1
GE - Georgia 1
IL - Israele 1
KE - Kenya 1
KR - Corea 1
MK - Macedonia 1
PY - Paraguay 1
RS - Serbia 1
TH - Thailandia 1
UZ - Uzbekistan 1
Totale 19.611
Città #
Fairfield 2.683
Woodbridge 1.516
Houston 1.073
Ashburn 1.060
Seattle 957
Chandler 945
Cambridge 909
Ann Arbor 839
Wilmington 800
Singapore 639
Jacksonville 530
Santa Clara 420
Boardman 391
Princeton 361
San Diego 276
Roxbury 198
Medford 171
Beijing 152
Des Moines 145
Padova 136
Hong Kong 135
Helsinki 132
Nanjing 110
Dong Ket 81
London 48
Guangzhou 41
Milan 39
New York 38
Shenyang 37
Hebei 30
Nanchang 28
Changsha 25
Norwalk 25
Jinan 24
Dublin 22
Redwood City 21
Jiaxing 20
Nuremberg 19
Ogden 19
Vicenza 18
Tianjin 17
Rome 16
Kilburn 15
Los Angeles 15
Washington 14
Kharkiv 10
Bologna 9
Fremont 9
Abidjan 8
Borås 8
Lanzhou 8
Vienna 8
Frankfurt am Main 7
Hounslow 7
Ningbo 7
Palermo 7
Prescot 7
Renton 7
São Paulo 7
Aguascalientes 6
Arezzo 6
Falkenstein 6
Hefei 6
Shanghai 6
Sydney 6
Toronto 6
Venice 6
Verona 6
Acton 5
Bucharest 5
Dallas 5
Lappeenranta 5
Munich 5
Phoenix 5
Redmond 5
Taizhou 5
Auckland 4
Bari 4
Brussels 4
Chicago 4
Chiswick 4
Hangzhou 4
Kunming 4
Las Vegas 4
New Bedfont 4
Scandolara Ravara 4
Stavanger 4
Zhengzhou 4
Adria 3
Amsterdam 3
Auburn Hills 3
Bergamo 3
Bolzaneto 3
Boulder 3
Brasília 3
Cairo 3
Dearborn 3
Detroit 3
Dongguan 3
Durango 3
Totale 15.477
Nome #
Role of alpha5beta1 integrin and MIA (melanoma inhibitory activity) in the pathogenesis of vitiligo. 227
Aggressive merkel cell carcinoma after janus kinase inhibitor ruxolitinib for polycythemia vera 158
Chaperone patterns in vernal keratoconjunctivitis are distinctive of cell and Hsp type, and are modified by inflammatory stimuli 150
Two-years of home based functional electrical stimulation recovers epidermis from atrophy and flattening after years of complete Conus-Cauda Syndrome 149
C2 is superior to C0 as predictor of renal toxicity and rejection risk profile in stable heart transplant recipients. 149
Association between Toll-like receptor 7 Gln11Leu single-nucleotide polymorphism and basal cell carcinoma 148
Adaptive immune responses in primary cutaneous sarcoidosis 145
A comparative study of the cutaneous side effects between BRAF monotherapy and BRAF/MEK inhibitor combination therapy in patients with advanced melanoma: A single-centre experience 141
Achromic superficial spreading melanoma accidentally treated with imiquimod. 136
Atypical skin reaction in a patient treated with gefitinib for advanced lung cancer: A case report and review of the literature 129
Primary cutaneous CD30+ anaplastic large cell lymphoma in a heart transplant patient: case report and literature review. 127
Functional impairment of p16(INK4A) due to CDKN2A p.Gly23Asp missense mutation. 123
Prognostic factors in merkel cell carcinoma: A retrospective single-center study in 90 patients 122
Immunosuppression and melanocyte proliferation. 121
Biochip technology for the serological diagnosis of bullous pemphigoid. 121
TLR7 Gln11Leu single nucleotide polymorphism and susceptibility to cutaneous melanoma 121
Latent tuberculosis infection in patients with chronic plaque psoriasis: Evidence from the Italian Psocare Registry 120
Prevalence of ALK gene alterations among the spectrum of plexiform spitzoid lesions 118
Vohwinkel syndrome: treatment of pseudo-ainhum. 118
Exacerbation of a Primary Follicular Centre Cutaneous B-cell Lymphoma during Pregnancy and Resolution to Anetoderma After Delivery 116
Acne Keloidalis of the Scalp in a Renal Transplant Patient Treated with Cyclosporine 115
Recent advances in localized immunotherapy of skin cancers 115
Analysis of immunoglobulin variable kappa gene mutations in cutaneous B-cell lymphoma 114
Immunotherapy-related skin toxicity: bullous pemphigoid in a lung adenocarcinoma patient treated with the anti-PDL1 antibody atezolizumab 114
Basal cell carcinoma: 10-year experience with electrochemotherapy 114
Electrochemotherapy of superficial tumors – Current status:: Basic principles, operating procedures, shared indications, and emerging applications 114
In vitro evaluation of sunscreens: an update for the clinicians. 113
Rejection-mediated Regression of Melanocytic Naevi in an Immunosuppressed Organ Transplant Recipient. 113
Dermoscopic diagnosis of amelanotic/hypomelanotic melanoma 113
Epidermolysis bullosa acquisita in a 17-year-old boy with Crohn's disease 112
Sunscreen tests: Correspondence between in vitro data and values reported by the manufacturers 111
A case of malignant melanoma arising from an acquired agminated melanocytic naevus. 110
The use of Biochip immunofluorescence microscopy for the serological diagnosis of epidermolysis bullosa acquisita 110
Evaluation of anti-desmoglein-1 and anti-desmoglein-3 autoantibody titers in pemphigus patients at the time of the initial diagnosis and after clinical remission 110
Psoriasis induced by thalidomide in a patient with multiple myeloma 108
TNF blockade and cutaneous lupus erythematosus: where do we stand and where are we going? 107
Italian guidelines in pemphigus - adapted from the European Dermatology Forum (EDF) and European Academy of Dermatology and Venerology (EADV) 107
Multiple autoimmune skin manifestations in a patient with Crohn's disease treated with a tumor necrosis factor-alpha blocker 106
Successful treatment of pyoderma gangrenosum with granulocyte and monocyte adsorption apheresis 105
Effectiveness of different substrate materials for in vitro sunscreen tests 104
Dermoscopic Changes in Melanocytic Naevi in Children during Digital Follow-up. 104
Melanoma and immunosuppression. 104
Pigmented nodular melanoma: the predictive value of dermoscopic features using multivariate analysis. 104
The liver: Another organ involved in Muir Torre syndrome? 104
Cutaneous squamous cell carcinoma. Italian Guidelines by SIDeMaST adapted to and updating EADO/EDF/EORTC guidelines 102
MC1R variants in childhood and adolescent melanoma: a retrospective pooled analysis of a multicentre cohort 102
Topical photodynamic therapy of actinic keratosis in renal transplant recipients 102
Nevus Spilus and Melanoma: Case Report and Review of the Literature 101
Localised pseudoepitheliomatous hyperplasia: unusual cutaneous reaction pattern to tattoo. 101
Histopathological characteristics of subsequent melanomas in patients with multiple primary melanomas. 101
Salivary Samples for the Diagnosis of Pemphigus vulgaris Using the BIOCHIP Approach: a Pilot Study 101
Cutaneous Side Effects of Targeted Therapy and Immunotherapy for Advanced Melanoma 101
Persistent B lymphocyte depletion after an ultralow dose of rituximab for pemphigus vulgaris 101
Biochip detection of BP180 autoantibodies in blister fluid for the serodiagnosis of bullous pemphigoid: A pilot study 101
Melanoma of Unknown Primary: Evaluation of the Characteristics, Treatment Strategies, Prognostic Factors in a Monocentric Retrospective Study 101
Anetoderma in cutaneous marginal-zone-B-cell lymphoma 100
Primary cutaneous mantle cell lymphoma. 100
A Therapeutic and Diagnostic Multidisciplinary Pathway for Merkel Cell Carcinoma Patients 99
Excess of melanocytic nevi in a patient treated with natalizumab for multiple sclerosis. 98
Erythroderma in the era of biological therapies. 98
- “gd T-lymphocytes in oriental cutaneous leishmaniasis: occurrence and variable d gene expression” 97
Glutathione S-transferase and CYP1A1 gene polymorphisms and non-melanoma skin cancer risk in Italian transplanted patients 97
Contribution of susceptibility gene variants to melanoma risk in families from the Veneto region of Italy 97
The role of immunohistochemical analysis in the diagnosis of parapsoriasis. 97
Immunosuppression and melanocyte proliferation. 97
The use of biochip immunofluorescence microscopy for the diagnosis of Pemphigus vulgaris. 97
Near infrared photoimmunotherapy targeting the cutaneous lymphocyte antigen for mycosis fungoides 97
- “Angioimmunoblastic lymphadenopathy with dysproteinemia and dermal T-cell lymphoma.” 96
Facial Basal Cell Carcinoma: Analysis of Recurrence and Follow-up Strategies 96
Differences in clinicopathological features and distribution of risk factors in Italian melanoma patients 96
Primary cutaneous B-cell lymphoma other than marginal zone: Clinicopathologic analysis of 161 cases: Comparison with current classification and definition of prognostic markers 96
- “T-lymphocytes bearing the gd T-cell receptor in cutaneous lesions of Langerhans cell histiocytosis” 95
Relapse of pemphigus vulgaris after topical application of ingenol mebutate 95
A Case of Angioinvasive Cutaneous Anaplastic Large Cell Lymphoma Completely Regressed After Low-dose Systemic Methotrexate 94
Ultra-low dose rituximab for refractory pemghigus vulgaris: a pilot study 94
Skin disorders in patients transplanted in childhood 93
Melanoma in Adolescents and Young Adults: Evaluation of the Characteristics, Treatment Strategies, and Prognostic Factors in a Monocentric Retrospective Study 93
Skin cancer and other cutaneous disorders in liver transplant recipients. 92
Bullous scabies simulating pemphigoid. 92
- “Morphological and quantitative analyses of normal epidermal Langerhans cells using confocal scanning laser microscopy.” 91
Skin cancer in heart transplant recipients: frequency and risk factor analysis 91
Detection of autoantibodies against recombinant desmoglein 1 and 3 molecules in patients with pemphigus vulgaris: correlation with disease extent at the time of diagnosis and during follow-up 91
Clinicopathological predictors of recurrence in nodular and superficial spreading cutaneous melanoma: A multivariate analysis of 214 cases 91
Skin cancers in Italian lung transplant recipients: Incidence and risk factors analysis 91
Expression of the CD1a molecule in B- and T-lymphoproliferative skin conditions 90
Primary Cutaneous Posttransplant Lymphoproliferative Disorders in Solid Organ Transplant Recipients: A Multicenter European Case Series. 90
Citrobacter freundii sepsis in an immunosuppressed patient with pemphigus vulgaris 89
- “Functional defect in cells involved in Langerhans cell histiocytosis” 88
Analysis of p53 polymorphisms in individuals with multiple melanocytic nevi 88
TLR7 Gln11Leu single nucleotide polymorphism and response to treatment with imiquimod in patients with basal cell carcinoma: A pilot study 88
Squamous cell carcinoma. 88
Clinical and Dermoscopic Features of Nevi in Preschool Children in Padua 87
Squamous cell carcinoma 86
Meyerson's phenomenon in a patient affected by high-risk melanoma under treatment with interferon-α. 86
A case of psoriasis pustolosa palmaris induced by cetuximab 86
Atrophic pityriasis versicolor occurring in a patient with Sjögren's syndrome 86
Linear bullous lichen planus associated with nivolumab 86
Recurrent Kaposi sarcoma associated with Koebner phenomenon in two HIV-seronegative patients 86
The liver: another organ involved in Muir Torre syndrome? 85
Prognostic factors in primary cutaneous B-cell lymphoma: The Italian Study Group for Cutaneous Lymphomas 84
Totale 10.638
Categoria #
all - tutte 83.738
article - articoli 82.144
book - libri 187
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 693
Totale 166.762


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.182 0 0 0 0 0 0 0 0 447 346 220 169
2020/20212.919 139 225 89 159 91 184 98 261 509 204 378 582
2021/20223.326 124 343 398 241 286 167 113 340 233 60 294 727
2022/20232.206 482 173 23 193 397 276 9 182 297 27 106 41
2023/20241.184 73 145 158 119 94 97 64 29 59 36 182 128
2024/20253.232 30 515 244 190 808 205 260 502 478 0 0 0
Totale 19.920